Page 1 of Clinical Trials for "Clofibric Acid", 16 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Enrolling by invitation
The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Last Updated: February 6, 2012
Condition(s): Neutral Lipid Storage Disease
2
Active, not recruiting
ACCORD-MIND: Action to Control Cardiovascular Risk in Diabetes--Memory in Diabetes
Last Updated: August 18, 2011
Condition(s): Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus; Coronary Disease
3
Active, not recruiting
Nephropathy In Type 2 Diabetes and Cardio-renal Events
Last Updated: December 20, 2011
Condition(s): Diabetic Nephropathy
4
Terminated
Effect of a Fibrate and a Statin on Endothelial Dysfunction
Last Updated: March 29, 2011
Condition(s): Diabetes Mellitus; Metabolic Syndrome
5
Withdrawn
Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques
Last Updated: November 16, 2007
Condition(s): Atherosclerosis
6
Active, not recruiting
Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)
Last Updated: December 4, 2009
Condition(s): Diabetic Retinopathy
7
Completed
The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.
Last Updated: August 10, 2009
Condition(s): Low HDL Cholesterol
8
Recruiting
Triglyceride Lowering Study
Last Updated: July 7, 2009
Condition(s): Hypertriglyceridemia
9
Completed
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
Last Updated: July 21, 2011
Condition(s): Hypertriglyceridemia
10
Completed
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
Last Updated: August 20, 2008
Condition(s): Type II Diabetes Mellitus; Mixed Dyslipidemia
11
Recruiting
Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
Last Updated: November 30, 2009
Condition(s): Rhabdomyolysis; Myopathy; Acute Renal Failure; Neuroleptic Malignant Syndrome
12
Completed
High-Density Lipoprotein (HDL) Treatment Study
Last Updated: June 2, 2008
Condition(s): Coronary Arteriosclerosis; Hypoalphalipoproteinemias; Genetic Diseases, Inborn
13
Recruiting
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Last Updated: March 16, 2012
Condition(s): Cardiovascular Diseases
14
Active, not recruiting
Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL
Last Updated: December 13, 2011
Condition(s): Hypertriglyceridemia
15
Recruiting
The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes
Last Updated: April 22, 2010
Condition(s): Endothelial Dysfunction
16
Active, not recruiting
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Last Updated: December 4, 2009
Condition(s): Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, Type 2; Diabetes Mellitus; Coronary Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Clofibric+Acid%22

Page 1 of Clinical Trials for "Clofibric Acid", 16 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About